Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd. – Trademark Portfolio

Entity Type: 99

Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JARAFÖM. The owner is based in Jinhua ,Zhejiang.

NO.1 Huangcheng West Road

Jinhua ,Zhejiang 321102 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JARAFÖM
JARAFÖM
Registered 2020

Trademark Classifications

Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd. have?

Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd. file in?

Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd.'s most well-known trademarks?

Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd.'s registered trademark portfolio includes well-known marks such as JARAFÖM. These are among 1 currently registered trademark in the portfolio.

What is Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd.'s trademark registration success rate?

Lanxi Sino Knight Maternal and Infant Supplies Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.